The review includes a total of 30 patients diagnosed with EAC melanoma, supplemented by an additional case from the authors\' clinical experience. The role of Breslow thickness as a determining factor for the choice of surgery remains inconclusive due to limited available data. Sentinel lymph node biopsy and adjuvant therapy are sparingly employed, indicating the need for standardized guidelines. Patients in the study demonstrate a 50% overall survival rate at 5 years.
EAC Melanoma is a rare and aggressive malignancy with limited therapeutic guidelines. Surgical interventions, including wide local excision and lateral temporal bone resection, are the primary treatment options for patients without distant metastases.
该综述共包括30名诊断为EAC黑色素瘤的患者,由作者的临床经验补充。由于可用数据有限,Breslow厚度作为选择手术的决定因素的作用仍不确定。前哨淋巴结活检和辅助治疗很少使用,表明需要标准化指南。研究中的患者在5年时表现出50%的总生存率。
EAC黑色素瘤是一种罕见的侵袭性恶性肿瘤,治疗指南有限。手术干预,包括广泛的局部切除和颞骨外侧切除,是无远处转移患者的主要治疗选择。